BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37893602)

  • 21. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies about cervical cancer screening: A qualitative study of Roma women's (non)participation in cervical cancer screening in Romania.
    Andreassen T; Weiderpass E; Nicula F; Suteu O; Itu A; Bumbu M; Tincu A; Ursin G; Moen K
    Soc Sci Med; 2017 Jun; 183():48-55. PubMed ID: 28460211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
    Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge and attitude of Uyghur women in Xinjiang province of China related to the prevention and early detection of cervical cancer.
    Abudukadeer A; Azam S; Mutailipu AZ; Qun L; Guilin G; Mijiti S
    World J Surg Oncol; 2015 Mar; 13():110. PubMed ID: 25885660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge of cervical cancer and HPV vaccine in Bangladeshi women: a population based, cross-sectional study.
    Islam JY; Khatun F; Alam A; Sultana F; Bhuiyan A; Alam N; Reichenbach L; Marions L; Rahman M; Nahar Q
    BMC Womens Health; 2018 Jan; 18(1):15. PubMed ID: 29325530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence and awareness of human papillomavirus infection and cervical cancer screening results among reproductive-aged Georgian women.
    Butsashvili M; Abzianidze T; Kajaia M; Agladze D; Kldiashvili E; Bednarczyk R; McNutt LA; Kamkamidze G
    J Fam Plann Reprod Health Care; 2015 Oct; 41(4):265-71. PubMed ID: 25900523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Need for Cervical Cancer Control in HIV-Positive and HIV-Negative Women from Romania by Primary Prevention and by Early Detection Using Clinically Validated HPV/DNA Tests.
    Ursu RG; Onofriescu M; Luca A; Prisecariu LJ; Sălceanu SO; Nemescu D; Iancu LS
    PLoS One; 2015; 10(7):e0132271. PubMed ID: 26186361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer in Ethiopia: a review of the literature.
    Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
    Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria.
    Azuogu BN; Umeokonkwo CD; Azuogu VC; Onwe OE; Okedo-Alex IN; Egbuji CC
    Niger J Clin Pract; 2019 Sep; 22(9):1286-1291. PubMed ID: 31489868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
    Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
    PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer elimination in Italy: Current scenario and future endeavors for a value based prevention.
    Calabrò GE; Riccardi MT; D'Ambrosio F; Castagna C; Sapienza M; Millevolte R; Pellacchia A; Ricciardi R; de Vincenzo RP; de Waure C
    Front Public Health; 2022; 10():1010237. PubMed ID: 36530690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical Cancer, Human Papillomavirus Infection, and Vaccine-Related Knowledge: Awareness in Chinese Women.
    Yuanyue L; Baloch Z; Shanshan L; Yasmeen N; Xiaomei W; Khan JM; Xueshan X
    Cancer Control; 2018; 25(1):1073274818799306. PubMed ID: 30213198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
    Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
    Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowledge and Awareness of Human Papillomavirus Vaccination and Cervical Cancer among Men and Women in Japan: A Questionnaire Survey.
    Horio F; Ikeda T; Zaitsu M; Takebe D; Tabata A; Matsukura M; Fujii I; Uchida Y
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):1063-1071. PubMed ID: 36974562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cancer - causes and prevention of hpv infections in the opinions of young polish women: a cross-sectional survey.
    Kotowski A; Kotowska M; Warzyszyńska A; Szymusik I; Kosińska-Kaczyńska K; Fal AM
    Wiad Lek; 2019; 72(3):327-335. PubMed ID: 31050976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China.
    Ning YE; Liu Y; Xu XY; Zhang XY; Wang N; Zheng LQ
    J Cancer Educ; 2020 Dec; 35(6):1197-1205. PubMed ID: 31338812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes towards HPV self-sampling among women in Chengdu, China: A cross-sectional survey.
    He L; He J
    J Med Screen; 2020 Dec; 27(4):201-206. PubMed ID: 31896295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.